Welsis (WLSS) Cash & Equivalents (2022 - 2023)
Welsis (WLSS) posted quarterly Cash & Equivalents of $1368.0 for Q4 2023, down 90.43% year-over-year from $14292.0 in Q4 2022, and down 86.09% quarter-over-quarter from $9834.0 in Q3 2023.
Welsis (WLSS) Cash & Equivalents (2022 - 2023) Analysis & Trends
Welsis' Cash & Equivalents history runs 2 years deep, the most recent figure standing at $1368.0 for Q4 2023.
- In Q4 2023, Cash & Equivalents fell 90.43% year-over-year to $1368.0; the TTM figure through Dec 2023 stood at $1368.0 (down 90.43% YoY), while the FY2023 annual figure was $9834.0, down 47.42% from the prior year.
- Cash & Equivalents for Q4 2023 stood at $1368.0, down from $9834.0 in the prior quarter.
- The five-year high for Cash & Equivalents was $18703.0 in Q3 2022, with the low at $963.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 1.90 Bn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 550.38 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 265.37 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 502.51 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 286.22 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 298.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 12.65 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 273.60 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 246.80 Mn |
| 10 | Welsis | 1.65 Mn | 1.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,368.00 |
| Sep 30, 2023 | 9,834.00 |
| Jun 30, 2023 | 5,202.00 |
| Mar 31, 2023 | 963.00 |
| Dec 31, 2022 | 14,292.00 |
| Sep 30, 2022 | 18,703.00 |
| Jun 30, 2022 | 1,640.00 |